Worboys Philip D
SVP, Research & Transl Science at TBPH
- Sold, on record
- $743k
- Dollars the filings state
- Form 4 sales
- 4
- Latest Mar 9, 2021
- Form 144 notices
- 0
- Proposed sales
- Companies
- 1
- Filed as an executive or holder
Companies
- TBPHTheravance Biopharma, Inc.SVP, Research & Transl Science
Sales by reason
0
Routine
0
Plan not stated
0
No plan
0
Unusual
Form 4 sales per month, last 12 months.
Timeline
- 1 Form 4 sale TBPHPlan not statedSep 12, 2018 2018
Sold 6,393 shares at $28.50 ($182k)
Worboys Philip D, SVP, Translational Science
Sold 3.7% of holdings ($4.9M position)166,753 shares leftFirst sale on recordFiling
- 2 Form 4 sale TBPHPlan not statedAug 20, 2020 +708 days
Sold 17,103 shares at $18.00 ($308k)
Worboys Philip D, SVP, Research & Transl Science
Sold 4.9% of holdings ($6.3M position)333,252 shares leftFiling
- 3 Form 4 sale TBPHPlan not statedDec 3, 2020 +105 days
Sold 4,246 shares at $18.00 ($76k)
Worboys Philip D, SVP, Research & Transl Science
Sold 1.3% of holdings ($5.8M position)319,395 shares leftFiling
- 4 Form 4 sale TBPHPlan not statedMar 9, 2021 +96 days
Sold 8,829 shares at $20.00 ($177k)
Worboys Philip D, SVP, Research & Transl Science
Sold 2.5% of holdings ($7.1M position)343,679 shares leftFiling
Every transaction
Loading transactions…
Sales and notices (4)
| Source | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Mar 9, 2021 | Mar 11, 2021 | TBPH | SVP, Research & Transl Science | Form 4 sale | 8,829 | $177k | 2.5% | Plan not stated | SEC |
| Dec 3, 2020 | Dec 7, 2020 | TBPH | SVP, Research & Transl Science | Form 4 sale | 4,246 | $76k | 1.3% | Plan not stated | SEC |
| Aug 20, 2020 | Aug 24, 2020 | TBPH | SVP, Research & Transl Science | Form 4 sale | 17,103 | $308k | 4.9% | Plan not stated | SEC |
| Sep 12, 2018 | Sep 14, 2018 | TBPH | SVP, Translational Science | Form 4 sale | 6,393 | $182k | 3.7% | Plan not stated | SEC |